MIRA INFORM REPORT

Report Date :

26.06.2012

IDENTIFICATION DETAILS

Name :	BRUKER BIOSPIN INTERNATIONAL AG

Registered Office :	Aegeristrasse 52 Postfach 351 6301 Zug

Country :	Switzerland

Date of Incorporation :	11.03.1987

Com. Reg. No.:	170.3.012.524-6 / 466763

Legal Form :	Company limited by shares

Line of Business :	Wholesale of pharmaceutical goods

No. of Employees :	10-19

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory
Payment Behaviour :	No Complaints
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2012

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Switzerland

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Company name and address

Bruker BioSpin International AG

Operating address:

Aegeristrasse 52

Postfach 351

6301 Zug

Switzerland/CH

Telephone: 041 7104433

Fax: 041 7104570

Web site: http://www.bruker.com

E-mail: sales@bruker-biospin.ch

VAT-No.: CHE103881088

Profile

Established: 1987

Line of Business: Consumer goods wholesale

Industry Division: Wholesale trade

Industry-code (NACE): 4646 Wholesale of pharmaceutical goods

4669 Wholesale of other machinery and equipment

Import/Export: Import, Export

Banks: unknown

Operational Figures

Coverage: Company

Figures: estimated

Employees: 10-19

Activity

The business activities includes the marketing and distribution of scientific equipment for the analytical instrumentation and research.

Real Estate

Information on property ownership was not available.

Company Register

Company No: 170.3.012.524-6 / 466763

Legal form: Company limited by shares

Registration: 11.03.1987

Legal status: active

Responsible Register: Handelsregister des Kantons Zug

History: Date of Incorporation Statutes: 06.03.1987

Date of Statutes: 13.02.2008

Date of Statutes: 20.12.2007

Date of Statutes: 27.04.2005

Date of Statutes: 07.12.2001

Date of Statutes: 06.09.1999

Date of Statutes: 20.11.1996

Entry Deleted Name

11.12.2001 Bruker BioSpin International AG

11.12.2001 Bruker BioSpin International Ltd (Name translated)

11.12.2001 Bruker BioSpin International SA (Name translated)

14.09.1999 Bruker-Spectrospin Vertriebsgemeinschaft AG

14.09.1999 Bruker-Spectrospin Vertriebsgemeinschaft SA (Name translated)

14.09.1999 Bruker-Spectrospin Vertriebsgemeinschaft Corp. (Name translated)

14.09.1999 11.12.2001 Bruker International AG

14.09.1999 11.12.2001 Bruker International SA (Name translated)

14.09.1999 11.12.2001 Bruker International Ltd (Name translated)

Entry Deleted Legal domicile

active Zug, Switzerland

Entry Deleted Address

10.04.2007 Aegeristrasse 52, 6300 Zug/ZG, Switzerland/CH

10.04.2007 Gotthardstrasse 18, 6300 Zug/ZG, Switzerland/CH

Entry Deleted Capital

11.05.2005 Share Capital CHF 8'500'000, paidup CHF 8'500'000

Entry Deleted Capital Structure

11.05.2005 8'500 Registered shares of CHF 1'000.--

Entry Deleted Activity (original Language)

21.02.2008 Weltweiter An- und Verkauf, Import und Export, Lagerung und Transport von sowie Handel mit Produkten aller Art, insbesondere wissenschaftlichen Geräten für die analytische Messtechnik innerhalb der Bruker Gruppe; kann Finanzierungen für eigene oder fremde Rechnung vornehmen sowie Sicherungsgeschäfte, einschliesslich Garantien, Pfandbestellungen, Globalzessionen, Sicherungsübereignungen und Schadloshaltungserklärungen für verbundene Unternehmen und Dritte eingehen, auch wenn diese in deren ausschliesslichem Interesse liegen, Patente, Lizenzen und Herstellungsverfahren erwerben, entwickeln, verwalten und verwerten, mit Waren aller Art handeln, Grundstücke erwerben, halten und veräussern, Tochtergesellschaften errichten sowie sich an anderen Unternehmen beteiligen.

Entry Deleted Remarks (original Language)

active Publishing authority: SHAB.

Official Administration

Title Name

President Dr. Christoph Straub-Schmidli, Origin: Basel, Herzogenbuchsee, Switzerland, Residential address: Zug, Switzerland, joint signature of two

Chief Executive Dr. Werner E. Maas, Origin: Netherlands, Residential address: Merrimac , United States of America, joint signature of two, Registered since: 08.07.2010

Executive Director Roger Deutsch, Origin: Märstetten, Switzerland, Residential address: Uetikon am See, Switzerland, joint signature of two, Registered since: 15.04.2005

Management

Title Name

Director Roger Deutsch, Origin: Märstetten, Switzerland, Residential address: Uetikon am See, Switzerland, joint signature of two, Registered since: 15.04.2005

Vice-Director Dr. Kurt Schenker, Origin: Däniken, Switzerland, Residential address: Maur, Switzerland, joint signature of two, Registered since: 08.07.2010

Vice-Director Urs Widmer, Origin: Lindau, Switzerland, Residential address: Neftenbach, Switzerland, joint signature of two, Registered since: 08.07.2010

Member with procuration Peter Kistler, Origin: Reichenburg, Switzerland, Residential address: Jona, Switzerland, joint power of attorney of two, Registered since: 08.07.2010

Member with procuration Dr. Peter Scherer, Origin: Killwangen, Switzerland, Residential address: Dübendorf, Switzerland, joint power of attorney of two, Registered since: 13.07.2011

External Positions

Title Name

Auditor Ernst & Young AG, Residential address: Zürich, Switzerland, Registered since: 06.10.2008

Ultimate Parent Company

Name: Bruker Corporation

City/Country: Billerica, United States of America/US

Owner/-s

No. of Owner/-s: 1

Owner: The company is foreign owned.

Class: 100%

Name: Bruker Invest AG

City/Country: Zug, Switzerland/CH

Interest: 100.00% voting right, 100.00% capital interest

Sisters

Name: Bruker BioSpin AG

City/Country: Fällanden, Switzerland/CH

Investments

Class: 100%

Name: Bruker (Beijing) Technologies & services Co. Ltd.

City/Country: Beijing, China/CN

Interest: 100.00% voting right, 100.00% capital interest

Class: 100%

Name: Bruker BioSpin Pte Ltd.

City/Country: Singapore, Singapore/SG

Interest: 100.00% voting right, 100.00% capital interest

Class: 100%

Name: Bruker India Scientific Pvt Ltd.

City/Country: Mumbai, India/IN

Interest: 100.00% voting right, 100.00% capital interest

Class: 100%

Name: Bruker (Malaysia) SDN BHD

City/Country: Petaling Jaya, Malaysia/MY

Interest: 100.00% voting right, 100.00% capital interest

Class: 100%

Name: Bruker Russia LLC

City/Country: Moscow, Russia/RU

Interest: 100.00% voting right, 100.00% capital interest

Legal Actions

An updated legal action check is only available against proof of interest. e.g. a copy of an enquiry letter, and order or invoice relating to the subject company.

Credit Information

Financial Statements: The company does not disclose any financial statements. Third parties are not permitted any insight into the financial affairs. It is therefore difficult to make a proper assessment of the actual situation.

Financial Situation: The financial situation is in order.

Payment experiences: There are no objections regarding the payment of financial obligations.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.56.53
UK Pound	1	Rs.88.09
Euro	1	Rs.70.83

INFORMATION DETAILS

Report Prepared by :

PRL

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.